Literature DB >> 2648406

Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts.

J M Brown1, M A Grosso, L S Terada, G J Whitman, A Banerjee, C W White, A H Harken, J E Repine.   

Abstract

Hearts isolated from rats pretreated 24 hr before with endotoxin had increased myocardial catalase activity, but the same superoxide dismutase, glutathione peroxidase, glutathione reductase, and glucose-6-phosphate dehydrogenase activities, as hearts from untreated rats. Hearts isolated from rats pretreated with endotoxin 24 hr before also had increased myocardial function (decreased injury) after ischemia and reperfusion (Langendorff apparatus, 37 degrees C), as assessed by measurement of ventricular developed pressure, contractility (+dP/dt), and relaxation rate (-dP/dt), compared to control hearts. In contrast, hearts isolated from rats pretreated with endotoxin 1 hr before isolation or hearts perfused with endotoxin did not have increased catalase activity or decreased injury following ischemia and reperfusion. Aminotriazole pretreatment prevented increases in myocardial catalase activity and myocardial function after ischemia-reperfusion in hearts from endotoxin-pretreated rats. The results suggest that endotoxin pretreatment decreases cardiac ischemia-reperfusion injury and that increases in endogenous myocardial catalase activity contribute to protection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2648406      PMCID: PMC286944          DOI: 10.1073/pnas.86.7.2516

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  Direct effects of endotoxin on hepatocytes. Synthesis of a specific secretory protein.

Authors:  J E Mazuski; J L Platt; M A West; R L Simmons; H C Towle; F B Cerra
Journal:  Arch Surg       Date:  1988-03

2.  Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression.

Authors:  D H Perlmutter; C A Dinarello; P I Punsal; H R Colten
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

3.  Preparation and assay of superoxide dismutases.

Authors:  J D Crapo; J M McCord; I Fridovich
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

4.  Heat-shock response is associated with enhanced postischemic ventricular recovery.

Authors:  R W Currie; M Karmazyn; M Kloc; K Mailer
Journal:  Circ Res       Date:  1988-09       Impact factor: 17.367

Review 5.  The statistical method.

Authors:  J Worcester
Journal:  N Engl J Med       Date:  1966-01-06       Impact factor: 91.245

Review 6.  Interleukin-1 and the pathogenesis of the acute-phase response.

Authors:  C A Dinarello
Journal:  N Engl J Med       Date:  1984-11-29       Impact factor: 91.245

7.  Myocardial reperfusion: a double-edged sword?

Authors:  E Braunwald; R A Kloner
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

8.  Endotoxin increases superoxide dismutase in cultured bovine pulmonary endothelial cells.

Authors:  Y Shiki; B O Meyrick; K L Brigham; I M Burr
Journal:  Am J Physiol       Date:  1987-04

Review 9.  Oxygen-derived free radicals in postischemic tissue injury.

Authors:  J M McCord
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

10.  Potection from oxygen toxicity with endotoxin. Role of the endogenous antioxidant enzymes of the lung.

Authors:  L Frank; J Summerville; D Massaro
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

View more
  55 in total

1.  Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms.

Authors:  E Wang; Yan Feng; Ming Zhang; Lin Zou; Yan Li; Emmanuel S Buys; Peigen Huang; Peter Brouckaert; Wei Chao
Journal:  Anesthesiology       Date:  2011-03       Impact factor: 7.892

2.  Biological responses of sheep treated with endotoxin-contaminated superoxide dismutase and endotoxin preparations.

Authors:  C R Yagoda; A C Bylund-Fellenius; N Adner; H Kindahl
Journal:  Acta Vet Scand       Date:  1990       Impact factor: 1.695

Review 3.  Therapeutic targeting of innate immunity in the failing heart.

Authors:  Veli K Topkara; Sarah Evans; Weili Zhang; Slava Epelman; Lora Staloch; Philip M Barger; Douglas L Mann
Journal:  J Mol Cell Cardiol       Date:  2010-11-10       Impact factor: 5.000

4.  Reperfusion Injury: Basic Concepts and Protection Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

5.  Lipopolysaccharide preconditioning attenuates metabolic alteration induced by endotoxin shock: tissue-specific monitoring by microdialysis.

Authors:  Jyrki J Tenhunen
Journal:  Intensive Care Med       Date:  2003-03-20       Impact factor: 17.440

Review 6.  Toll-like receptors: new players in myocardial ischemia/reperfusion injury.

Authors:  Tuanzhu Ha; Li Liu; Jim Kelley; Race Kao; David Williams; Chuanfu Li
Journal:  Antioxid Redox Signal       Date:  2011-04-08       Impact factor: 8.401

7.  Monophosphoryl lipid A induces pharmacologic 'preconditioning' in rabbit hearts without concomitant expression of 70-kDa heat shock protein.

Authors:  K Yoshida; M M Maaieh; J B Shipley; M Doloresco; N L Bernardo; Y Z Qian; G T Elliott; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1996-06-07       Impact factor: 3.396

8.  Toll-like receptor 4 is essential to preserving cardiac function and survival in low-grade polymicrobial sepsis.

Authors:  Ming Zhang; Lin Zou; Yan Feng; Yu-Jung Chen; Qichang Zhou; Fumito Ichinose; Wei Chao
Journal:  Anesthesiology       Date:  2014-12       Impact factor: 7.892

9.  Peroxisomal participation in the cellular response to the oxidative stress of endotoxin.

Authors:  G S Dhaunsi; I Singh; C D Hanevold
Journal:  Mol Cell Biochem       Date:  1993-09-08       Impact factor: 3.396

10.  Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1.

Authors:  Pierre Sicard; Sebastien Jacquet; Koichi S Kobayashi; Richard A Flavell; Michael S Marber
Journal:  Cardiovasc Res       Date:  2009-02-12       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.